Polycaprolactone (PCL) Tricalcium Phosphate (TCP) Composite Scaffold for Bone Regeneration market was valued at USD 185 million in 2025 and is projected to reach USD 365 million by 2034, exhibiting a remarkable CAGR of 7.9% during the forecast period.
Polycaprolactone (PCL) and Tricalcium Phosphate (TCP) composite scaffolds represent advanced biomaterials designed specifically for bone tissue...